Studies investigating the HGF/MET pathway have been conducted in various cancer types, including NSCLC, breast cancer, head and neck cancer, colorectal cancer, gastric cancer, pancreatic cancer, and other gastrointestinal cancers. Here, HGF is linked to cancer.